cyclosporine has been researched along with Dermatitis, Contact in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 13 (56.52) | 18.2507 |
2000's | 6 (26.09) | 29.6817 |
2010's | 3 (13.04) | 24.3611 |
2020's | 1 (4.35) | 2.80 |
Authors | Studies |
---|---|
Braisted, J; Dranchak, P; Earnest, TW; Gu, X; Hoon, MA; Inglese, J; Oliphant, E; Solinski, HJ | 1 |
Abeywardane, A; Caviness, G; Choi, Y; Cogan, D; Gao, A; Goldberg, D; Heim-Riether, A; Jeanfavre, D; Klein, E; Kowalski, JA; Mao, W; Miller, C; Moss, N; Ramsden, P; Raymond, E; Skow, D; Smith-Keenan, L; Snow, RJ; Wu, F; Wu, JP; Yu, Y | 1 |
Allais, L; Briffaux, JP; Brisebard, E; Pallardy, M; Ravas, N | 1 |
Cassano, N; Garcovich, C; Garcovich, S; Vena, GA | 1 |
Abe, K; Kitano, Y; Natsuaki, M | 1 |
Brown, TP; Kim, Y; Pantin-Jackwood, MJ | 1 |
Fei, M; Wu, X; Xu, Q | 1 |
Ikeda, K; Shimizu, Y; Sugahara, S; Yamamoto, S | 1 |
Gardiner, P | 1 |
Kanerva, L | 1 |
Puigneró, V; Queralt, J | 1 |
Hiyama, H; Inagaki, N; Kawada, K; Matsuo, A; Nagai, H; Ueda, Y | 1 |
Erkko, P; Granlund, H; Reitamo, S | 1 |
Bonanno, CT; Caccamo, N; Cigna, D; Dieli, F; Dominici, R; Ferro, C; Salerno, A; Sireci, G | 1 |
Fisher, GJ; Reynolds, NJ; Voorhees, JJ | 1 |
Araki, M; Furue, M; Imafuku, S; Shimada, S; Tamaki, K | 1 |
Bull, DF; Elfers, A; Exton, MS; Jeong, WY; Schedlowski, M; Westermann, J | 1 |
Meingassner, JG; Stütz, A | 1 |
Stütz, A | 1 |
Chapman, FA; Cramer, DV; Hreha-Eiras, G; Jaffee, BD; Jones, EA; Knoop, M; Makowka, L | 1 |
Ayala, F; Balato, N; Lembo, G; Patruno, C | 1 |
Büchner, S; Itin, P; Maibach, HI; Surber, C | 1 |
Bos, JD; De Rie, MA; Meinardi, MM | 1 |
2 review(s) available for cyclosporine and Dermatitis, Contact
Article | Year |
---|---|
Complementary, holistic, and integrative medicine: chamomile.
Topics: Chamomile; Colic; Conjunctivitis; Cyclosporine; Dermatitis; Dermatitis, Contact; Diarrhea; Dyspepsia; Female; Flowers; Herb-Drug Interactions; Humans; Infant; Lactation; Morning Sickness; Phytotherapy; Plant Extracts; Plant Preparations; Pregnancy; Warfarin | 2007 |
Immunosuppressive macrolides.
Topics: Animals; Anti-Bacterial Agents; Carrier Proteins; Cyclosporine; Dermatitis, Atopic; Dermatitis, Contact; Disease Models, Animal; Guinea Pigs; Immunosuppressive Agents; Mice; Polyenes; Receptors, Drug; Receptors, Immunologic; Sirolimus; Swine; Tacrolimus; Tacrolimus Binding Proteins | 1992 |
2 trial(s) available for cyclosporine and Dermatitis, Contact
Article | Year |
---|---|
Effect of a new topical cyclosporin formulation on human allergic contact dermatitis.
Topics: Administration, Cutaneous; Cyclosporine; Dermatitis, Contact; Humans; Male | 1992 |
Lack of efficacy of topical cyclosporin A in atopic dermatitis and allergic contact dermatitis.
Topics: Administration, Cutaneous; Cyclosporine; Dermatitis, Atopic; Dermatitis, Contact; Double-Blind Method; Drug Administration Schedule; Humans; Nickel; Ointments; Skin; Suspensions | 1991 |
19 other study(ies) available for cyclosporine and Dermatitis, Contact
Article | Year |
---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, Spinal; Humans; Mice, Inbred C57BL; Mice, Knockout; Neurons; Pruritus; Receptors, Atrial Natriuretic Factor; Reproducibility of Results; Signal Transduction; Small Molecule Libraries | 2019 |
N-Arylsulfonyl-α-amino carboxamides are potent and selective inhibitors of the chemokine receptor CCR10 that show efficacy in the murine DNFB model of contact hypersensitivity.
Topics: Amides; Animals; Carboxylic Acids; Cell Line; Dermatitis, Contact; Dinitrofluorobenzene; Disease Models, Animal; Humans; Mice; Receptors, CCR10; Structure-Activity Relationship | 2016 |
Skin immune cell characterization in juvenile and adult Göttingen Minipigs.
Topics: Age Factors; Animals; Cyclosporine; Dermatitis, Contact; Female; Immunity, Cellular; Immunosuppressive Agents; Male; Pregnancy; Skin; Swine; Swine, Miniature | 2021 |
Cyclosporine A microemulsion in dermatological practice: is oral solution better tolerated than soft gelatin capsules?
Topics: Administration, Oral; Adolescent; Adult; Aged; Capsules; Cyclosporine; Dermatitis, Atopic; Dermatitis, Contact; Emulsions; Female; Gelatin; Humans; Immunosuppressive Agents; Middle Aged; Pharmaceutical Solutions; Psoriasis | 2015 |
Flare-up reaction on murine contact hypersensitivity. III. Effect of staphylococcal enterotoxin B.
Topics: Animals; Antibodies; Cyclosporine; Dermatitis, Contact; Dinitrofluorobenzene; Dose-Response Relationship, Drug; Ear; Enterotoxins; Female; Haptens; Injections, Intravenous; Mice; Mice, Inbred BALB C; Time Factors; Tumor Necrosis Factor-alpha | 2002 |
Effects of cyclosporin A treatment on the pathogenesis of avian leukosis virus subgroup J infection in broiler chickens with Marek's disease virus exposure.
Topics: Animals; Antibodies, Viral; Avian Leukosis; Avian Leukosis Virus; Body Weight; Chickens; Cyclosporine; Dermatitis, Contact; Flow Cytometry; Immunocompromised Host; Immunohistochemistry; Immunophenotyping; Immunosuppressive Agents; Lymphocyte Activation; Marek Disease; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; T-Lymphocytes; Viremia | 2003 |
Astilbin inhibits contact hypersensitivity through negative cytokine regulation distinct from cyclosporin A.
Topics: Animals; Antibody Formation; Carrier Proteins; Cyclosporine; Dermatitis, Contact; Female; Flavonols; Immunosuppressive Agents; Interleukin-10; Lymphocyte Activation; Lymphocytes; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Repressor Proteins; Suppressor of Cytokine Signaling 1 Protein; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins | 2005 |
Pharmacological profile of a novel phosphodiesterase 7A and -4 dual inhibitor, YM-393059, on acute and chronic inflammation models.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acute Disease; Animals; Anti-Inflammatory Agents; Carrageenan; Chronic Disease; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclic Nucleotide Phosphodiesterases, Type 7; Cyclosporine; Dermatitis, Contact; Edema; Erythrocytes; Fumarates; Hypersensitivity, Delayed; Immunosuppressive Agents; Indoles; Inflammation; Male; Mice; Mice, Inbred BALB C; Peritonitis; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Sheep; Sulfonamides; Toluene 2,4-Diisocyanate; Zymosan | 2006 |
Occupational allergic contact dermatitis from epoxy resin in a dental nurse with primary sensitization during cyclosporine treatment.
Topics: Aged; Benzhydryl Compounds; Carcinogens; Cyclosporine; Dental Staff; Dermatitis, Allergic Contact; Dermatitis, Contact; Dermatitis, Occupational; Epoxy Compounds; Female; Graft Rejection; Hand Dermatoses; Humans; Immunization; Immunosuppressive Agents; Kidney Transplantation | 1996 |
Effect of topically applied cyclosporin A on arachidonic acid (AA)- and tetradecanoylphorbol acetate (TPA)-induced dermal inflammation in mouse ear.
Topics: Acetylglucosaminidase; Administration, Topical; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Capillary Permeability; Cyclooxygenase Inhibitors; Cyclosporine; Dermatitis, Contact; Dexamethasone; Eicosanoids; Glucocorticoids; Immunosuppressive Agents; Indomethacin; Lipoxygenase Inhibitors; Male; Mice; Peroxidase; Pyrazoles; Tetradecanoylphorbol Acetate | 1997 |
FK-506 and cyclosporin A potentiate the IgE antibody production by contact sensitization with hapten in mice.
Topics: Animals; Cyclosporine; Cytokines; Dermatitis, Contact; Dinitrofluorobenzene; Female; Haptens; Immunoglobulin E; Immunosuppressive Agents; Mice; Mice, Inbred BALB C; Tacrolimus; Th1 Cells | 1997 |
Long-term follow-up of eczema patients treated with cyclosporine.
Topics: Adult; Cyclosporine; Dermatitis, Atopic; Dermatitis, Contact; Eczema; Female; Follow-Up Studies; Hand; Humans; Immunosuppressive Agents; Male; Photosensitivity Disorders | 1998 |
The effect of cyclosporin A, FK506 and rapamycin on the murine contact sensitivity reaction.
Topics: Animals; Cyclosporine; Dermatitis, Contact; Immunosuppressive Agents; Lymphocyte Activation; Male; Mice; Mice, Inbred CBA; Picryl Chloride; Polyenes; Receptors, Antigen, T-Cell, alpha-beta; Receptors, Antigen, T-Cell, gamma-delta; Sirolimus; T-Lymphocyte Subsets; Tacrolimus | 1998 |
Cyclosporin A inhibits 12-O-tetradecanoyl-phorbol-13-acetate-induced cutaneous inflammation in severe combined immunodeficient mice that lack functional lymphocytes.
Topics: Animals; Cyclosporine; Dermatitis, Contact; Epidermis; Immune Tolerance; Immunosuppressive Agents; Lymphocytes; Mice; Mice, SCID; Tetradecanoylphorbol Acetate | 1998 |
Activation pattern of Langerhans cells in the afferent and efferent phases of contact hypersensitivity.
Topics: Animals; Cyclosporine; Dermatitis, Contact; Dexamethasone; Female; Langerhans Cells; Mice; Mice, Inbred C3H; Picryl Chloride | 1999 |
Conditioned suppression of contact sensitivity is independent of sympathetic splenic innervation.
Topics: Animals; Conditioning, Classical; Cyclosporine; Denervation; Dermatitis, Contact; Dinitrochlorobenzene; Edema; Epinephrine; Male; Norepinephrine; Rats; Saccharin; Skin; Spleen; Sympathetic Nervous System | 2000 |
Immunosuppressive macrolides of the type FK 506: a novel class of topical agents for treatment of skin diseases?
Topics: Animals; Clobetasol; Cyclosporine; Dermatitis, Contact; Dexamethasone; Disease Models, Animal; Female; Molecular Structure; Polyenes; Sirolimus; Swine; Tacrolimus | 1992 |
The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat.
Topics: Animals; Biphenyl Compounds; Cyclosporine; Dermatitis, Contact; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Heart Transplantation; Immune Tolerance; Immunosuppressive Agents; Kidney Transplantation; Liver Transplantation; Lymphocyte Culture Test, Mixed; Mice; Mice, Inbred BALB C; Rats; Rats, Inbred ACI; Rats, Inbred BN; Rats, Inbred Lew; Transplantation, Heterotopic; Transplantation, Homologous | 1992 |
Influence of topically applied cyclosporin A in various vehicles on patch test reactions.
Topics: Administration, Topical; Adult; Animals; Cyclosporine; Dermatitis, Contact; Female; Guinea Pigs; Humans; Patch Tests; Pharmaceutical Vehicles | 1992 |